Jan Vishwas Bill sparks concerns that makers of substandard drugs will get off lightly
A key change to the Drugs and Cosmetics Act that it proposes will allow pharma companies to simply pay a fine for manufacturing substandard drugs and avoid jail time, warn activists.
31 July, 2023•1 min
0
31 July, 2023•1 min
0
More in
Nation
What the NCLAT’s ruling on WhatsApp and Meta means for data and competition
By upholding a Rs 213-crore penalty against Meta but also striking down a data-sharing ban, the tribunal has highlighted the limits of the CCI’s powers and the need to align privacy and competition regulation.
You may also like
Nation
What the NCLAT’s ruling on WhatsApp and Meta means for data and competition
By upholding a Rs 213-crore penalty against Meta but also striking down a data-sharing ban, the tribunal has highlighted the limits of the CCI’s powers and the need to align privacy and competition regulation.
Nation
Can insurers deny your claim over using E20 fuel?
Most petrol pumps across India today offer petrol blended with 20% ethanol, which can damage your vehicle if it is not compatible.
Nation
ANI’s copyright strikes aren’t the problem, its access is
The news agency is being questioned for enforcing its copyright. But the government needs to be asked why ANI is given such exclusive access in the first place.